Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
alpha-tocopherolquinone is an oxidized derivative of alpha-tocopherol (vitamin E). It belongs to the class of diterpenoids and is also known as vitamin E quinone. This compound has been identified in various plants and biological systems. Pharmacologically, it exhibits potent anticoagulant activity, likely through inhibition of the vitamin K-dependent gamma-glutamyl carboxylase enzyme, which prevents carboxylation of glutamyl residues in coagulation factors, thereby inhibiting platelet aggregation and blood clotting[2][4]. Additionally, it can downregulate mitochondrial respiratory activity and displays antioxidant properties after reduction to tocopherylhydroquinone[5]. Its precise mechanism of action remains incompletely elucidated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alpha-tocopherolquinone.